Correlation Between Mineralys Therapeutics, and Annexon

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Annexon, you can compare the effects of market volatilities on Mineralys Therapeutics, and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Annexon.

Diversification Opportunities for Mineralys Therapeutics, and Annexon

-0.4

Correlation Coefficient

Mineralys Therapeutics,  Annexon

Very good diversification

The 3 months correlation between Mineralys and Annexon is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Annexon go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Annexon

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Annexon. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.61 times less risky than Annexon. The stock trades about -0.03 of its potential returns per unit of risk. The Annexon is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  165.00  in Annexon on May 6, 2025 and sell it today you would earn a total of  80.00  from holding Annexon or generate 48.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Annexon

Mineralys Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Annexon

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Annexon showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mineralys Therapeutics, and Annexon

The main advantage of trading using opposite Mineralys Therapeutics, and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.

The idea behind Mineralys Therapeutics, Common and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.